全文获取类型
收费全文 | 2084篇 |
免费 | 185篇 |
国内免费 | 62篇 |
专业分类
耳鼻咽喉 | 56篇 |
儿科学 | 90篇 |
妇产科学 | 97篇 |
基础医学 | 277篇 |
口腔科学 | 39篇 |
临床医学 | 257篇 |
内科学 | 321篇 |
皮肤病学 | 20篇 |
神经病学 | 178篇 |
特种医学 | 113篇 |
外科学 | 282篇 |
综合类 | 87篇 |
一般理论 | 1篇 |
预防医学 | 183篇 |
眼科学 | 29篇 |
药学 | 175篇 |
中国医学 | 4篇 |
肿瘤学 | 122篇 |
出版年
2022年 | 12篇 |
2021年 | 24篇 |
2020年 | 21篇 |
2019年 | 20篇 |
2018年 | 15篇 |
2017年 | 32篇 |
2016年 | 25篇 |
2015年 | 38篇 |
2014年 | 41篇 |
2013年 | 70篇 |
2012年 | 69篇 |
2011年 | 62篇 |
2010年 | 58篇 |
2009年 | 64篇 |
2008年 | 60篇 |
2007年 | 118篇 |
2006年 | 76篇 |
2005年 | 73篇 |
2004年 | 80篇 |
2003年 | 74篇 |
2002年 | 85篇 |
2001年 | 78篇 |
2000年 | 92篇 |
1999年 | 68篇 |
1998年 | 52篇 |
1997年 | 54篇 |
1996年 | 45篇 |
1995年 | 34篇 |
1994年 | 26篇 |
1993年 | 38篇 |
1992年 | 34篇 |
1991年 | 58篇 |
1990年 | 59篇 |
1989年 | 69篇 |
1988年 | 54篇 |
1987年 | 51篇 |
1986年 | 33篇 |
1985年 | 40篇 |
1984年 | 37篇 |
1983年 | 17篇 |
1982年 | 14篇 |
1981年 | 19篇 |
1980年 | 16篇 |
1979年 | 29篇 |
1978年 | 23篇 |
1977年 | 17篇 |
1976年 | 19篇 |
1975年 | 15篇 |
1974年 | 15篇 |
1972年 | 14篇 |
排序方式: 共有2331条查询结果,搜索用时 15 毫秒
101.
In vitro and in vivo antitumor properties of the cyclin dependent kinase inhibitor CYC202 (R-roscovitine) 总被引:4,自引:0,他引:4
McClue SJ Blake D Clarke R Cowan A Cummings L Fischer PM MacKenzie M Melville J Stewart K Wang S Zhelev N Zheleva D Lane DP 《International journal of cancer. Journal international du cancer》2002,102(5):463-468
CDK2 inhibitors have been proposed as effective anti-cancer therapeutics. We show here that CYC202 (R-roscovitine) is a potent inhibitor of recombinant CDK2/cyclin E kinase activity (IC(50) = 0.10 microM) with an average cytotoxic IC(50) of 15.2 microM in a panel of 19 human tumour cell lines, and we also demonstrate selectivity for rapidly proliferating cells over non-proliferating cells. A study of the cell cycle effects of CYC202 in Lovo colorectal carcinoma cells showed that the major effect was not the predicted arrest in one part of the cycle, but rather an induction of cell death from all compartments of the cell cycle. The maximum tolerated dose given intravenously to mice was in excess of 20 mg/kg. Doses up to 2,000 mg/kg were tolerated when administered orally in mice. Following repeated intraperitoneal administration (3 times daily for 5 days) of 100 mg/kg to nude mice bearing the Lovo human colorectal tumour, CYC202 induced a significant antitumour effect with a 45% reduction in tumour growth compared to controls. A second experiment using the human uterine xenograft MESSA-DX5 treated with orally administered CYC202 (500 mg/kg 3 times daily for 4 days) also exhibited a significant reduction in the rate of growth of the tumour (62%). These data, showing enzyme and cellular potency together with antitumour activity, confirm the potential of CDK2 inhibitors such as CYC202 as anticancer drugs. 相似文献
102.
103.
New Zealand community attitudes toward people with epilepsy 总被引:3,自引:3,他引:0
PURPOSE: International surveys on knowledge and attitudes toward people with epilepsy suggest that public opinion is improving in many countries. This study aimed to discover how New Zealand compared with other countries, and how subgroups within the New Zealand population compared with each other, by conducting a survey of community knowledge and attitudes toward epilepsy. METHODS: Telephone interviews were conducted on a random sample of 400 persons older than 17 years, drawn from a mid-sized provincial town and its hinterland. RESULTS: Ninety-five percent of respondents had heard or read about epilepsy; 73% knew someone with epilepsy; and 67% had seen an epileptic seizure. Somewhat less knowledgeable were young people, the less educated, lower socioeconomic status (SES), and those of Maori or non-European ethnicity. Attitudes toward people with epilepsy were favorable, with only 5% objecting to their child marrying a person who sometimes had seizures. Less-positive attitudes were found among some older people. CONCLUSIONS: Compared with those in other Western countries, New Zealanders are well informed about epilepsy, and their attitudes toward it are mainly positive. Continuing public education about epilepsy is still necessary, especially among the young, the non-European, and older people. 相似文献
104.
105.
Wang LM Zhang Q Zhu W He C Lu CL Ding DF Chen ZY 《第二军医大学学报》2005,26(11):1299-1299
Glial cell line-derived neurotrophic factor (GDNF) plays a critical role in neurodevelopment and survival of midbrain dopaminergic and spinal motor neurons in vitro and in vivo. The biological actions of GDNF are mediated by a two-receptor complex consisting of a glycosylphosphatidylinositol-linked cell surface molecule, the GDNF family receptor alpha 1 (GFR alpha 1), and receptor protein tyrosine kinase Ret. Although structural analysis of GDNF has been extensively examined, less is known about the structural basis of GFR alpha 1 function. In this study, based on evolutionary trace method and relative solvent accessibility prediction of residues, a set of trace residues that are solvent-accessible was selected for site-directed mutagenesis. A series of GFR alpha 1 mutations was made, and PC12 cell lines stably expressing different GFR alpha 1 mutants were generated. According to the survival and differentiation responses of these stable PC12 cells upon GDNF stimulation and the GDNF- GFR alpha 1-Ret interaction assay, residues 152NN153, Arg259, and 316SNS318 in the GFR alpha 1 central region were found to be critical for GFR alpha 1 binding to GDNF and eliciting downstream signal transduction. The single mutation R259A in the GFR alpha 1 molecule simultaneously lost its binding ability to GDNF and Ret. However N152A/N153A or S316A/N317A/ S318A mutation in the GFR alpha 1 molecule still retained the ability to bind with Ret. These findings suggest that distinct structural elements in GFR alpha 1 may be involved in binding to GDNF and Ret. 相似文献
106.
107.
LT Lucato AM McKinney J Short M Teksam CL Truwit 《Journal of Medical Imaging and Radiation Oncology》2006,50(4):364-368
A 35‐year‐old woman presented with neurotoxicity correlated to an i.v. regimen of 5‐fluorouracil as episodes of acute confusional state and abnormalities of symmetrically restricted diffusion in the periventricular white matter and corpus callosum. On discontinuing the medication, the areas of severely restricted diffusion had entirely resolved, with minimal residual T2 signal abnormality. In this case, immediate discontinuation of the chemotherapeutic agent apparently reversed the patient's symptoms and findings on MRI. The scant information available in the published literature regarding this phenomenon is reviewed with regard to 5‐fluorouracil. 相似文献
108.
109.
S El-Sayed A Nabid W Shelley J Hay J Balogh M Gelinas R MacKenzie N Read E Berthelet H Lau J Epstein P Delvecchio P K Ganguly F Wong P Burns D Tu J Pater 《Journal of clinical oncology》2002,20(19):3956-3963
PURPOSE: Mucositis occurs in almost all patients treated with radiotherapy for head and neck cancer. The aim of this multicenter, double-blind, prospective, randomized trial was to evaluate the clinical efficacy of an economically viable antimicrobial lozenge (bacitracin, clotrimazole, and gentamicin [BcoG]) in the alleviation of radiation-induced mucositis in patients with head and neck cancer. PATIENTS AND METHODS: One hundred thirty-seven eligible patients were randomized to treatment with either antimicrobial lozenge (69 patients) or placebo lozenge (68 patients). The primary end point of the study was the time to development of severe mucositis from the start of radiotherapy. Secondary end points included severity and duration of mucositis, pain measurement, radiation therapy interruption, and quality of life. Mucositis was scored using a validated mucositis scoring system. RESULTS: Toxicity profiles were similar between the two arms of the study. The median time to development of severe mucositis from the start of radiotherapy was 3.61 weeks on BCoG and 3.96 weeks on placebo (P =.61). There were no statistically significant differences between the arms in the extent of severe mucositis as measured by physician, in oral toxicities as recorded by patients, or in radiotherapy delays. CONCLUSION: This study was conducted on the basis of a pilot study that demonstrated the BCoG lozenge to be tolerable and microbiologically efficacious. A validated mucositis scoring system was used. However, in this group of patients treated with conventional radiotherapy, the lozenge did not impact significantly on the severity of mucositis. Whether such a lozenge would be beneficial in treatment situations where rate of severe mucositis is higher (ie, in patients treated with unconventional fractionation or with concomitant chemotherapy) is unknown. 相似文献
110.
Holt R Rask P Coulthard KP Sinclair M Roberts G Van Der Walt J MacKenzie V Rasmussen M 《Paediatric anaesthesia》2000,10(2):181-188
The 5-HT3 antagonists are effective in reducing postoperative nausea and vomiting (PONV) associated with paediatric tonsillectomy. Although prophylactic tropisetron can reduce the incidence of PONV by half, the resulting level of over 40% is still unacceptably high. The aim of this study was to evaluate the effect of adding dexamethasone to tropisetron. In a blinded study, 59 children (mean age 6.1 years) were administered 0.1 mg.kg-1 up to 2 mg of tropisetron and 66 children (mean age 5.7 years) received the same dose of tropisetron plus 0.5 mg.kg-1 up to 8 mg of dexamethasone. Both drugs were given intravenously during induction of anaesthesia for tonsillectomy. During the inpatient stay of 24 h, the incidence of postoperative vomiting in the tropisetron alone group was 53% compared with 26% in the combination group (P=0.002, chi-squared). A significant reduction in nausea from 53% to 30% was also observed (P=0.02). Parents completed a daily diary for 5 days following discharge. Delayed vomiting occurred in 27% and 11% of the tropisetron and combination therapy groups, respectively (P=0.025) Sixteen percent and 9%, respectively, required medical attention (P=0.27). Tropisetron plus dexamethasone is more effective than tropisetron alone in reducing the incidence of PONV following paediatric tonsillectomy. 相似文献